Genomic_landscape_of_feline_mammary_tumours

Although only a few targeted therapies are currently approved for use in veterinary medicine, their use is likely to increase given the marked success of such agents in human cancer treatment. However, this will only be possible if genomic alterations found in canine and feline cancers can be effectively identified. Thus we propose to sequence tumour-germline pairs of commonly occurring cancer types in dogs and cats, to help define the landscape driver genes in companion animal cancers thus promoting precision oncology and advances in our understanding of the etiology of these diseases. The cases in this cohort are feline mammary carcinomas.